These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24803202)

  • 21. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).
    Erdine S; Ro YM; Tse HF; Howes LG; Aguilar-Salinas CA; Chaves H; Guindy R; Chopra P; Moller RA; Schou IM;
    J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel.
    Anderson TJ; Grégoire J; Hegele RA; Couture P; Mancini GB; McPherson R; Francis GA; Poirier P; Lau DC; Grover S; Genest J; Carpentier AC; Dufour R; Gupta M; Ward R; Leiter LA; Lonn E; Ng DS; Pearson GJ; Yates GM; Stone JA; Ur E
    Can J Cardiol; 2014 Apr; 30(4):377-80. PubMed ID: 24589194
    [No Abstract]   [Full Text] [Related]  

  • 23. Madelung's disease.
    Yeh NC; Yang CY; Chou CW; Yen FC; Lee SY; Tien KJ
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3012-3. PubMed ID: 22701018
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of cardiovascular risk: the importance of meeting lipid targets.
    Gotto AM; Moon JE
    Am J Cardiol; 2012 Jul; 110(1 Suppl):3A-14A. PubMed ID: 22697390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of lipid profiles and attainment of lipid goals in patients <65 years versus patients ≥65 years (from the Lipid Treatment Assessment Project [L-TAP] 2).
    Rodriguez F; Santos RD; Messig M; Tarasenko L; Ferrières J; Jukema JW; Chiang CW; Waters DD; Foody JM;
    Am J Cardiol; 2012 Jun; 109(12):1738-42. PubMed ID: 22440124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment for dyslipidemias in patients with arterial hypertension].
    Chazova IE; Kukharchuk VV; Ratova LG; Kaminnaia VI
    Ter Arkh; 2007; 79(4):53-7. PubMed ID: 17564020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.
    Poussa H; Strandberg TE; Tikkanen I; Kauhanen P; Lepäntalo M
    Scand Cardiovasc J; 2007 Jun; 41(3):138-41. PubMed ID: 17487761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of dyslipidemia in 2014: European versus American guidelines].
    Radermecker RP
    Rev Med Suisse; 2014 Aug; 10(439):1534-7. PubMed ID: 25272669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attainment of low-density lipoprotein cholesterol goals in coronary artery disease.
    Kauffman AB; Olson KL; Youngblood ML; Zadvorny EB; Delate T; Merenich JA;
    J Clin Lipidol; 2010; 4(3):173-80. PubMed ID: 21122649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
    Maddox TM; Borden WB; Tang F; Virani SS; Oetgen WJ; Mullen JB; Chan PS; Casale PN; Douglas PS; Masoudi FA; Farmer SA; Rumsfeld JS
    J Am Coll Cardiol; 2014 Dec; 64(21):2183-92. PubMed ID: 25447259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

  • 32. Will obesity increase the proportion of children and adolescents recommended for a statin?
    McCrindle BW; Tyrrell PN; Kavey RE
    Circulation; 2013 Nov; 128(19):2162-5. PubMed ID: 24190936
    [No Abstract]   [Full Text] [Related]  

  • 33. Cholesterol and peripheral vascular disease: a neglected topic?
    Atar D; Jørgensen JJ
    Scand Cardiovasc J; 2007 Jun; 41(3):136-7. PubMed ID: 17487760
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current guidelines for treatment of dyslipidemia in kidney diseases].
    Jędras M; Dylewska M
    Wiad Lek; 2014; 67(3):426-8. PubMed ID: 25782205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM; Farmer JA
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of low-density lipoprotein targets.
    Whayne TF
    Angiology; 2013 Aug; 64(6):411-6. PubMed ID: 22734087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternate-day dosing of statins for secondary prevention of coronary artery disease/The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels.
    Celik M; Celik T
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):253; author reply 253-4. PubMed ID: 19520663
    [No Abstract]   [Full Text] [Related]  

  • 38. Association of Statin Use With Cardiovascular Outcomes by Coronary Calcium: MESA.
    Zhou Z; Ong KL; Breslin M; Allison MA; Curtis AJ; Nelson MR
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):1094-1096. PubMed ID: 31928940
    [No Abstract]   [Full Text] [Related]  

  • 39. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary risk prevention in the elderly: use clinician-patient discussions, not automatic statin prescribing.
    Stone NJ; Blum CB
    Am J Med; 2015 Aug; 128(8):804-6. PubMed ID: 25820167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.